SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently garnering significant community attention as traders debate its role in institutional adoption, with many users actively discussing its potential for recovery amidst broader crypto market volatility. Community sentiment remains polarized, featuring a mix of long-term holders focused on staking and developers pushing various meme-based projects on the chain.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term utility versus short-term price action, with significant focus on an upcoming token unlock and high expectations for major partnerships in the pipeline. Investors are actively discussing the project's potential integration with institutional rails like XRP and Stellar, fueling a narrative of long-term holding despite current market volatility.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is trending as retail investors rally around its potential for a short squeeze amid escalating Middle East tensions and rising global oil prices. The community is heavily focused on the geopolitical impact on supply chains and energy infrastructure, with many debating the impact of insider activity versus bullish sentiment regarding energy sector independence.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon stock is currently trending due to a combination of escalating Middle East geopolitical risks impacting AWS cloud infrastructure in Bahrain and increased institutional interest driven by positive analyst target adjustments. While short-term traders are reacting to bearish flow divergence and regional conflict volatility, long-term investors are heavily debating the stock's valuation as a foundational AI play versus broader market concerns over consumer spending and potential recessionary headwinds.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh strong 1Q26 booking momentum and expanding defense sector partnerships against disappointing quarterly revenue and wider-than-expected losses. The community is actively debating the stock's long-term valuation as a speculative "quantum pure-play" while navigating intense volatility driven by competitive pressures from other industry players and broader macroeconomic uncertainty.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets ($SSB) is currently trending as community members rally behind its recent launch, actively pushing for exchange listings and requesting updated charts to track momentum. Investors are highlighting the project's ambitious ecosystem plans and decentralized finance features, while discussions frequently emphasize the potential for long-term growth and the active involvement of the SatoshiStreetBets community.

Global X Funds - Global X Defense Tech ETF

Global X Defense Tech ETF

The Global X Defense Tech ETF is seeing significant momentum as investors capitalize on surging global military spending and persistent geopolitical tensions, with many in the community viewing it as a strategic long-term play for aerospace and autonomous technology. Traders are actively debating the integration of artificial intelligence and robotics into defense platforms, with many highlighting the ETF's diversified exposure to both domestic and international contractors as a key hedge against macroeconomic uncertainty.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is trending due to surging interest in its European gas fields amid heightened geopolitical instability and supply concerns in the energy sector. Investors are closely monitoring the stock's tight float and high cost-to-borrow fees, with community discussions heavily focused on the potential for a short squeeze and the added leverage provided by the company's warrants.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors react to a significant analyst upgrade and anticipate the upcoming presentation of Phase 3 long-term clinical data at the American Academy of Dermatology conference. The community is actively discussing the stock's potential for acquisition, with ongoing debates centered on whether recent price volatility is driven by institutional accumulation or tactical suppression by market makers.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is surging following FDA approval of Vykat XR to treat hyperphagia in Prader-Willi syndrome patients, marking the first therapy of its kind for this rare disease. The community is actively discussing the stock's significant valuation shift, potential for commercial success, and ongoing speculation regarding its status as a high-conviction buyout candidate for larger pharmaceutical players.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Are Shares Of Wellgistics Health Falling?

Shares of Wellgistics Health Inc. are trading lower after announcing a letter of intent to evaluate the acquisition of Neuritek Therapeutics.read more...

Wednesday, 13 August 2025 08:30 AMTopic:&nbsp;<h4>Company Update</h4>&nbsp;TAMPA, FLORIDA / <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.accessnewswire.com/">ACCESS Newswire</a> / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.The program operates in partnership with RxERP, a serialized pharmaceutical eCommerce and ERP (Enterprise Resource Planning) system that manages onboarding, transactions, and reporting for participating pharmacies. With Wellgistics already serving more than 6,500 independent pharmacies and over 200 manufacturers nationwide, the Company is well-positioned to accelerate adoption rapidly and at scale.Pharmacies can now enroll in the beta program at:<a target="_blank" rel="noopener noreferrer nofollow" href="https://pr.report/d8zp">https://wellgisticshealth.com/xrp-in-healthcare/</a>How Pharmacies Benefit from Using XRP<ul><li>Instant Settlement - Payments settle in seconds, not days</li><li>Lower Fees - Avoid credit card and bank transaction costs</li><li>24/7 Availability - No banking delays, even on weekends and holidays</li><li>Improved Cash Flow - Faster access to working capital and inventory restock</li><li>Real-Time Tracking - View and confirm payments instantly</li><li>No Intermediaries - Direct transactions between pharmacy and distributor</li></ul>"We've been impressed with the response so far," said Brian Norton, CEO of Wellgistics Health. "Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry. Our mission is to give pharmacies greater control, speed, and transparency in their financial operations."Technical Innovation and Blockchain IntegrationThe XRP Payment Program harnesses the speed, scalability, and low-cost infrastructure of the XRP Ledger to meet the unique demands of the pharmaceutical supply chain. Integrated with RxERP, the platform delivers real-time, encrypted, and fully compliant payment processing tailored for independent pharmacies, wholesalers and in the near future, manufacturers.Pharmacies and investors can learn more by downloading the Wellgistics Health XRP E-Book:<a target="_blank" rel="noopener noreferrer nofollow" href="https://pr.report/d8zq">https://wellgisticshealth.com/xrp-in-healthcare/</a>Regulatory Compliance and SecurityThe XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements. The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage.Next Phase: Manufacturer Onboarding and Direct-to-Patient (DTP) ProgramsFollowing the pharmacy rollout, Wellgistics Health will begin onboarding pharmaceutical manufacturers to the XRP platform-expanding capabilities for direct, on-chain transactions. The Company also plans to launch manufacturer-powered Direct-to-Patient (DTP) programs, allowing manufacturers to ship medications directly to patients' homes in collaboration with their community pharmacy and prescribing physicians to ensure clinical continuity and compliance."Pharmacies deserve a payment system as fast and responsive as the care they provide," said Tony Madsen, COO of Wellgistics Health. "While this first phase focuses on helping pharmacies pay for products more efficiently, it's just the start. Our vision is to make every aspect of pharmacy payments faster, clearer, and completely frictionless."About Wellgistics HealthWellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, providing wholesale distribution, digital prescription routing, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health offers compliant, end-to-end solutions that restore access, transparency, and trust in U.S. healthcare.About RxERPRxERP is the only serialized pharmaceutical ERP system designed specifically for independent pharmacies, wholesalers, and manufacturers. It delivers real-time financial, operational, and compliance tools-integrating blockchain, AI, and serialized inventory management to streamline operations and modernize the supply chain. RxERP is the platform partner managing the XRP Implementation Program with Wellgistics Health.Forward-Looking StatementsThis press release may contain forward-looking statements regarding Wellgistics Health's plans, strategies, future operations, and expected performance. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could affect these results include, but are not limited to, market conditions and risks detailed in filings with the SEC. Investors are cautioned not to place undue reliance on forward-looking statements. Additional information is available at www.sec.gov.Media Contact: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:media@wellgisticshealth.com">media@wellgisticshealth.com</a> Investor Relations: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:investors@wellgisticshealth.com">investors@wellgisticshealth.com</a>Investor Relations Contact: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, NY 10036 Office: (646) 893-5835 Email: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:info@skylineccg.com">info@skylineccg.com</a>SOURCE: Wellgistics Health, Inc.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies

https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/wellgistics-health-nasdaq-wgrx-launches-xrp-payment-program-for-indep-1060334

Others

Wellgistics Health, Inc., a holding company focused on pharmaceuticals and healthcare services, has drawn significant retail investor attention since going public on Feb. 21.&nbsp;Despite closing below its $4.50 IPO price on day one, the Tampa, Florida-based company has seen its Stocktwits follower count surge by over 960%, with a six-fold increase in the last week alone, the highest for any healthcare firm on Stocktwits during this period.Message volume on the platform about the stock has also skyrocketed by 10,800% since its market debut.So, what's fueling the buzz? Let's break down the key developments since the IPO.Strategic Partnerships &amp; Product ExpansionLate last month, Wellgistics announced an agreement with Tollo Health to market its proprietary medical food products, addressing the side effects of GLP-1 treatments and long-term COVID-19.&nbsp;Tollo's flagship product, Galectovid, is designed to manage dietary Galectin-1 and 3-associated viral infections, muscle loss, and gut discomfort linked to GLP-1 drug use.Earlier this month, Wellgistics partnered with Protega Pharmaceuticals, the maker of Roxybond, an FDA-approved abuse-deterrent opioid pain medication.&nbsp;The collaboration aims to enhance pharmacist education on abuse-deterrent pain management and expand access to Roxybond, particularly in underserved rural areas, via Wellgistics' independent pharmacy clients.Leadership Change &amp; Compliance MilestoneEarlier this month, Wellgistics appointed Brian Norton as its new CEO, replacing Tim Canning. Under his leadership, the company plans to improve operational efficiency, optimize sales, advance its technology roadmap, and explore acquisition opportunities.Retail investors on Stocktwits took note of Norton's Fox Business&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.foxbusiness.com/video/6370288081112">interview</a> on Thursday, in which he said U.S. pharmacy benefit managers (PBMs) had failed to lower drug prices and instead led to rising costs.&nbsp;He said Wellgistics aims to address this by providing affordable medications and ensuring safe opioid administration.&nbsp;<stembedurl>https://stocktwits.com/Paraboljoker/message/608773239</stembedurl>Norton also advocated for scrutinizing PBMs, supporting independent pharmacies, and ensuring pricing transparency to empower patients.Since its Nasdaq debut in February, Wellgistics stock has climbed more than 8%, signaling strong investor confidence in the newcomer.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Retail Traders Are Rushing Into Small-Cap Wellgistics Health Weeks After Its Nasdaq Debut

The CEO has said the company aims to address the failures of pharmacy benefit managers by providing affordable medications and ensuring safe opioid administration.

Equity

The CEO has said the company aims to address the failures of pharmacy benefit managers by providing affordable medications and ensuring safe opioid administration.


Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

Wellgistics Health Inc.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

WGRX
Wellgistics Health Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest WGRX News

WGRXWellgistics Health Inc.